Showing results (931-940 of 3,103) with videos related to
Sort By:
Pageof 311
Drug Safety|June 30, 2015
The Risk of Opioid Intoxications or Related Events and the Effect of Alcohol-Related Disorders: A Retrospective Cohort Study in German Patients Treated with High-Potency Opioid AnalgesicsK Jobski, B Kollhorst, T Schink, et al.Drug Safety|May 24, 2015
Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry AnalysisYoshinori Takeuchi, Kazuhiro Kajiyama, Chieko Ishiguro, et al.Drug Safety|April 28, 2015
Oral anticoagulants and risk of nephropathyVinay Narasimha Krishna, David G Warnock, Nakshatra Saxena, et al.Drug Safety|August 19, 2016
Neuropsychiatric Effects of HIV Antiviral MedicationsGlenn J Treisman, Olivia SoudryDrug Safety|August 19, 2016
Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic DilemmasRashmi R ShahDrug Safety|June 20, 2020
Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med ProjectBissan Audeh, Florelle Bellet, Marie-Noëlle Beyens, et al.Drug Safety|June 20, 2020
The Effect of Positively Framing Side-Effect Risk in Two Different Formats on Side-Effect Expectations, Informed Consent and Credibility: A Randomised Trial of 16- to 75-Year-Olds in EnglandRebecca K Webster, G James RubinDrug Safety|May 6, 2020
Critical Assessment of Pharmacokinetic Drug-Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis TreatmentVijayabhaskar Veeravalli, Ranjeet P Dash, Jennifer A Thomas, et al.Drug Safety|April 17, 2020
Erice Call for Change: Utilising Patient Experiences to Enhance the Quality and Safety of HealthcareElena Rocca, Rani Lill AnjumDrug Safety|June 17, 2015
DNA Barcoding and Pharmacovigilance of Herbal MedicinesHugo J de Boer, Mihael C Ichim, Steven G NewmasterPageof 311